Edesa Biotech (EDSA) EBIT Margin (2013 - 2020)
Edesa Biotech's EBIT Margin came in at -402094.80% for fiscal Q4 2020 (quarter ended Sep 30, 2020), down 400486.91 percentage points from the prior quarter.
Powered by 
Analysis
Edesa Biotech (EDSA) EBIT Margin (2013 - 2020) Analysis & Trends
For FY2020 (ended Sep 30, 2020), Edesa Biotech's EBIT Margin was -1946.72%, down 1257.42 percentage points from FY2019.
- EBIT Margin carries a five-year change of -1374.87 percentage points (FY2015 to FY2020).
- Going back by fiscal year, EBIT Margin was -689.30% in FY2019 (+1707.81 pp), -2397.11% in FY2018 (-108.52 pp), -2288.59% in FY2017 (-1902.62 pp) and -385.97% in FY2016 (+185.88 pp).
- The fiscal Q4 2020 figure represents the lowest quarterly EBIT Margin in data going back to fiscal Q1 2014.
- The fastest year-over-year change in EBIT Margin over five years came in fiscal Q4 2018 (a gain of 45345.04 percentage points), and the weakest in fiscal Q4 2017 (a drop of 47054.30 percentage points).
- Business Quant data shows EDSA's EBIT Margin at -1607.89% (Q3 2020), -1371.98% (Q2 2020) and -1025.68% (Q1 2020) in the three fiscal quarters before Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Edesa Biotech | 35.16 Mn | 35.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -402,094.80% |
| Jun 30, 2020 | -1,607.89% |
| Mar 31, 2020 | -1,371.98% |
| Dec 31, 2019 | -1,025.68% |
| Jun 30, 2019 | -264,070.80% |
| Sep 30, 2018 | -2,186.10% |
| Mar 31, 2018 | -2,098.07% |
| Dec 31, 2017 | -6,784.20% |
| Sep 30, 2017 | -47,531.15% |
| Jun 30, 2017 | -6,300.49% |
| Mar 31, 2017 | -1,820.97% |
| Dec 31, 2016 | -997.12% |
| Sep 30, 2016 | -476.85% |
| Jun 30, 2016 | -656.28% |
| Mar 31, 2016 | -335.83% |
| Dec 31, 2015 | -267.81% |
| Sep 30, 2015 | -477.31% |
| Jun 30, 2015 | -702.12% |
| Mar 31, 2015 | -763.62% |
| Dec 31, 2014 | -668.36% |
API Access
Edesa Biotech EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();